Lam Research Rides Semiconductor Super-Cycle with Record $14.6B Revenue, 45.1% Margins
•1 min read
Revenue
$14.6B ( YoY) with systems $10.2B () and services $4.4B ()
↑+45%
Rd Spend
$1.5B ( YoY) at of revenue
↑+22%
Net Income
$3.9B ( YoY) with net margin (+400bps)
↑+71%
Gross Margin
(+130bps YoY) driven by mix and efficiencies
↑46.1%
Free Cash Flow
$3.7B ( YoY) with conversion rate
↑+75%
Operating Margin
(+320bps YoY) with strong operating leverage
↑31.7%
Growth Indicators
$5.1B ( of total, YoY)
↑35%
Deferred Revenue↑$1.1B (+52% YoY)
Customer Concentration↑Top 2 customers 43% of revenue (vs 36% FY20)
Lam Research delivered exceptional FY2021 performance with revenue surging 45% to $14.6B amid unprecedented semiconductor demand. Gross margins expanded 130bps to 46.1% despite supply chain constraints, driven by operational efficiencies and pricing power. The company's leadership in etch and deposition technology positions it to capture growth from rising semiconductor capital intensity. Management expects sustained momentum from memory, foundry and logic customers as chip shortages persist into 2022.
Key Risks
China exposure (35% of revenue) amid ongoing trade tensions
Customer concentration with top 2 at 43% of revenue
Supply chain constraints impacting costs and lead times
Cyclical industry dynamics despite structural growth
Memory capacity additions as pricing environment improves
Services growth from expanding installed base
New markets in advanced packaging and selective etch
Bottom Line
Lam Research delivered outstanding FY2021 results while positioning for sustainable long-term growth. Record revenue of $14.6B and expanding margins demonstrate strong execution despite macro challenges. The company's technology leadership in critical semiconductor manufacturing processes provides competitive advantages as industry capital intensity rises. While customer concentration and geopolitical risks warrant monitoring, multiple growth vectors support continued momentum. Key metrics to watch include gross margin trajectory, China exposure, and supply chain normalization timeline.